Steven Clifford

Professor Steven Clifford is a faculty member at Newcastle University specializing in pediatric neuro-oncology, with primary focus on medulloblastoma—the most common malignant brain tumor in children. His research integrates molecular biology, clinical oncology, and translational medicine to improve therapeutic strategies for childhood brain cancers.

His research interests center on molecular subgrouping of medulloblastoma, identification of metabolic vulnerabilities (particularly MYC-driven pathways), and optimization of clinical protocols through multicenter collaborations. Key areas include epigenetic regulation, tumor evolution, and biomarker discovery for precision medicine applications in pediatric patients.

Recent publications (2024-2025) demonstrate consistent focus on molecular characterization techniques (bisulfite sequencing, metabolite profiling), clinical trial analysis (HIT 2000, SJMB03), and therapeutic target identification. His work frequently addresses radiotherapy late-effects, surgical outcomes, and consensus treatment guidelines through European research networks.

Professor Clifford maintains active collaborations with SIOP-Europe and multiple international institutions, evidenced by co-authorship on large cohort studies involving over 1,100 patients. His research directly informs clinical practice through consensus guidelines and novel diagnostic approaches for molecular subgroup detection.